Literature DB >> 4114341

Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers.

M B Mosher, R C DeConti, J R Bertino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4114341     DOI： 10.1002/1097-0142(197207)30:1<56::aid-cncr2820300109>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Bleomycin-Coated Microneedles for Treatment of Warts.

Authors:  Han Sol Lee; Ha Ryeong Ryu; Joo Young Roh; Jung-Hwan Park
Journal:  Pharm Res       Date:  2016-11-17       Impact factor: 4.200

Review 2.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Hyperpigmentation after bleomycin therapy. Ultrastructural study.

Authors:  H Perrot; J P Ortonne
Journal:  Arch Dermatol Res       Date:  1978-05-31       Impact factor: 3.017

4.  Kinetically-based multiple drug treatment for advanced head and neck cancer.

Authors:  L A Price; B T Hill; A H Calvert; H J Shaw; K B Hughes
Journal:  Br Med J       Date:  1975-07-05

5.  Fulminant hyperpyrexia induced by bleomycin.

Authors:  W H Leung; J Y Lau; T K Chan; C R Kumana
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

6.  A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.

Authors:  F Rosenfelt; J Palmer; I Weinstein; B Rosenbloom
Journal:  Yale J Biol Med       Date:  1982 Sep-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.